Group prenatal care
BehavioralEnrolled subjects will be randomly assigned in a 2:1 ratio to group or traditional care.
NCT Number: NCT03301792
The investigators primary objective is to conduct a randomized trial to determine the effect of diabetes group prenatal care on glycemic control and postpartum weight retention in women with type 2 diabetes and gestational diabetes.
This study is active but is not currently recruiting participants.
Notify Me18 year–50 year
Female
Interventional
Not applicable
Washington University in St. Louis, St Louis, Missouri, United States
Long term, the investigator aims to test the central hypothesis that group prenatal care, compared to traditional prenatal care, will improve, 1.) glycemic control and, 2.) postpartum weight retention in women with type 2 and gestational diabetes. The objective of this proposal is to conduct a randomized trial in two phases to determine the effect of Diabetes Group Care (GC) on glycemic control in pregnant women with T2DM and GDM (Antepartum Phase) and the impact on postpartum weight retention (Postpartum Phase).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Enrolled subjects will be randomly assigned in a 2:1 ratio to group or traditional care.
Time frame: Initial study visit (22-34 weeks) through one year postpartum
Determine the effect of Diabetes Group care on maternal glycemic control by randomizing women to Diabetes group care or traditional care and compare 1) Mean fasting blood glucose, 2) Mean 1-hour post-prandial blood glucose, and 3) Hemoglobin A1c at delivery, 4-12 weeks postpartum, six months postpartum, one year postpartum
Time frame: Pre-pregnancy weight (up to 6 months prior to initial visit) through one year postpartum
Determine the impact of Diabetes Group care on postpartum weight retention in pounds based on postpartum weight retention at one year. Average weight retention will be compared at 4-12 weeks, six months postpartum, and one year postpartum.
Time frame: 37-39 weeks gestation
Determine the effect of Diabetes Group care on maternal diabetes self-care activities by using the Diabetes Self-care Activities Scale (a measure of the number of days during the prior week in which the subject followed diet, exercise, blood sugar testing, and medication adherence recommendations)
Time frame: Initial study visit (22-34 weeks) through 39 weeks gestation
Determine the effect of Diabetes Group care by measuring the percentage of recommended blood glucose values entered on logs since initial study visit
Time frame: Initial study visit (22-34weeks) through 4-12 weeks postpartum
Determine the effect of Diabetes Group Care on maternal antepartum compliance by assessing the number of prenatal appointments attended
Time frame: Initial study visit (22-34weeks) through one year postpartum
Determine the effect of Diabetes Group Care on maternal antepartum physical activity/eating behavior using a physical activity/eating behavior questionnaire
Time frame: Initial study visit (22-34weeks) through delivery
Determine the effect of Diabetes Group Care on maternal antepartum weight gain in pounds
Time frame: Delivery through 4-12 weeks postpartum
Determine the effect of Diabetes Group Care on maternal intrapartum mode of delivery by assessing whether infant was delivered spontaneously, using vacuum, forceps, or cesarean.
Time frame: Delivery through 4-12 weeks postpartum
Determine the effect of Diabetes Group Care on maternal intrapartum hypertensive disorders of pregnancy by assessing whether they develop gestational hypertension, preeclampsia, or eclampsia.
Time frame: 4-12 weeks postpartum
Determine the effect of Diabetes Group Care on maternal postpartum readmission by assessing number of maternal hospital readmissions within 6 weeks postpartum.
Time frame: 4-12 weeks postpartum
Determine the effect of Diabetes Group Care on maternal postpartum visit attendance by assessing whether she attends a postpartum visit between 4-12 weeks postpartum.
Time frame: 4-12 weeks postpartum
Determine the effect of Diabetes Group Care on maternal postpartum glucose testing
Time frame: 4-12 weeks postpartum, six months postpartum, one year postpartum
Determine the effect of Diabetes Group Care on maternal postpartum breastfeeding using a breastfeeding scale questionnaire
Time frame: 4-12 weeks postpartum, six months postpartum, one year postpartum
Determine the effect of Diabetes Group Care on maternal postpartum contraception choices by assessing use of short acting reversible contraception, long acting reversible, and sterilization.
Time frame: delivery admission
Determine the effect of Diabetes Group Care on neonatal birth weight in grams
Time frame: delivery admission
Determine the effect of Diabetes Group Care on neonatal gestational age at delivery
Time frame: delivery admission
Determine the effect of Diabetes Group Care on neonatal APGAR score
Time frame: delivery admission through one year postpartum
Determine the effect of Diabetes Group Care on neonatal adiposity and body composition by air displacement plethysmography within 1 week of delivery. Skin fold thickness of triceps, subscapular, ilium, and thigh at delivery, six weeks, six months, one year postpartum.
Time frame: delivery through one year postpartum
Determine the effect of Diabetes Group Care on neonatal weight in grams
Time frame: delivery through one year postpartum
Determine the effect of Diabetes Group Care on neonatal length in centimeters
Time frame: delivery through one year postpartum
Determine the effect of Diabetes Group Care on neonatal head circumference in centimeters
Time frame: delivery admission
Determine the effect of Diabetes Group Care on neonatal NICU admission
Time frame: delivery admission
Determine the effect of Diabetes Group Care on neonatal hypoglycemia
Time frame: delivery admission
Determine the effect of Diabetes Group Care on neonatal hematocrit
Time frame: delivery admission
Determine the effect of Diabetes Group Care on neonatal jaundice
Time frame: delivery admission
Determine the effect of Diabetes Group Care on neonatal stillbirth rates
Time frame: Initial study visit (22-34weeks) through one year postpartum
Determine the effect of Diabetes Group Care on psychosocial stress by comparing Cohen's Perceived Stress at study entry visit, last study visit (37-39 weeks) and 4-12 weeks postpartum, six months postpartum, one year postpartum.
Time frame: Initial study visit (22-34weeks) and six months postpartum
Determine the effect of Diabetes Group Care on psychosocial stress by comparing life events checklist at study entry visit and six months postpartum
Time frame: Initial study visit (22-34 weeks) through 4-12 weeks postpartum
Determine the effects of Diabetes Group Care on psychosocial stress by comparing Pregnancy Distress questionnaire at study entry, last study visit (37-39 weeks), and 4-12 weeks postpartum
Time frame: Initial study visit (22-34weeks) through one year postpartum
Determine the effects of Diabetes Group Care on psychosocial stress by comparing GAD-7 at study entry, last study visit (37-39weeks) and 4-12 weeks postpartum, six months postpartum, one year postpartum.
Time frame: Initial study visit (22-34weeks) through 1 year postpartum
Determine the effects of Diabetes Group Care on depression by comparing the Edinburgh Postnatal Depression Scale at study entry, last study visit (37-39 weeks) and 4-12 weeks postpartum, six months postpartum, one year postpartum
Time frame: Delivery through postpartum
Determine the effects of Diabetes Group Care on stress and depression by measuring alcohol or drug use in first year postpartum
Washington University School of Medicine
Other
Group Versus Traditional Prenatal Care for Diabetes: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02444325
Diabetes Mellitus, Diabetes Mellitus, Type 2
Denver, Colorado, United States
View Trial DetailsNCT04090307
Diabetes Mellitus, Diabetes, Gestational
St Louis, Missouri, United States
View Trial DetailsNCT01346527
Cardiovascular Diseases, Diabetes Mellitus
St Louis, Missouri, United States
View Trial DetailsNCT06628453
Diabetes Mellitus, Diabetes Mellitus, Type 2
Birmingham, Alabama, United States
View Trial Details